Tactile Systems Technology (TCMD) Liabilities and Shareholders Equity (2015 - 2026)
Tactile Systems Technology (TCMD) posted quarterly Liabilities and Shareholders Equity of $272.1 million for Q1 2026, down 2.9% year-over-year from $280.2 million in Q1 2025, and down 0.67% quarter-over-quarter from $273.9 million in Q4 2025.
Tactile Systems Technology (TCMD) Liabilities and Shareholders Equity (2015 - 2026) Analysis & Trends
Tactile Systems Technology (TCMD) has reported Liabilities and Shareholders Equity for 12 consecutive years, with $272.1 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Liabilities and Shareholders Equity fell 2.9% year-over-year to $272.1 million; the TTM figure through Mar 2026 stood at $1.1 billion (down 5.8% YoY), while the FY2025 annual figure was $273.9 million, down 8.05% from the prior year.
- Liabilities and Shareholders Equity eased to $272.1 million in Q1 2026 per TCMD's latest filing, from $273.9 million in the prior quarter.
- Across five years, Liabilities and Shareholders Equity topped out at $297.9 million in Q4 2024 and bottomed at $233.0 million in Q1 2022.
- Historically, Liabilities and Shareholders Equity has averaged $270.2 million across 5 years, with a median of $273.7 million in 2023.
- Annual changes were most pronounced in 2022 — Liabilities and Shareholders Equity soared 32.94% — and 2025, when it dropped 9.92%.
- Tactile Systems Technology's Liabilities and Shareholders Equity stood at $255.0 million in 2022, then advanced by 10.37% to $281.4 million in 2023, then gained by 5.86% to $297.9 million in 2024, then decreased by 8.05% to $273.9 million in 2025, then dropped by 0.67% to $272.1 million in 2026.
- Business Quant data shows TCMD's Liabilities and Shareholders Equity at $272.1 million in Q1 2026, $273.9 million in Q4 2025, and $259.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | 109.22 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 47.93 Bn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 93.03 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 45.22 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 13.87 Bn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 6.46 Bn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 37.25 Bn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 31.04 Bn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 10.74 Bn |
| 10 | Tactile Systems Technology | 542.20 Mn | 457.42 Mn | 65.35 Mn | 279.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 279.67 Mn |
| Mar 31, 2026 | 272.12 Mn |
| Dec 31, 2025 | 273.94 Mn |
| Sep 30, 2025 | 259.18 Mn |
| Jun 30, 2025 | 273.05 Mn |
| Mar 31, 2025 | 280.24 Mn |
| Dec 31, 2024 | 297.92 Mn |
| Sep 30, 2024 | 287.72 Mn |
| Jun 30, 2024 | 278.78 Mn |
| Mar 31, 2024 | 272.04 Mn |
| Dec 31, 2023 | 281.44 Mn |
| Sep 30, 2023 | 293.31 Mn |
| Jun 30, 2023 | 273.73 Mn |
| Mar 31, 2023 | 275.50 Mn |
| Dec 31, 2022 | 255.00 Mn |
| Sep 30, 2022 | 248.53 Mn |
| Jun 30, 2022 | 237.30 Mn |
| Mar 31, 2022 | 233.01 Mn |
| Dec 31, 2021 | 244.27 Mn |
| Sep 30, 2021 | 249.40 Mn |